| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |